COMORBID OSTEOPOROSIS: CHALLENGES AND NEW DIAGNOSTIC OPPORTUNITIES (Part 1)

Download full text PDF
Issue: 
10
Year: 
2017

O. Jones (1), Candidate of Medical Sciences; Professor V. Strukov (2), MD; Professor A. Kislov (2), MD; Professor N. Eremina (2), MD; Professor M. Kondrachenko (2), MD; T. Kuptsova (3) 1-Mansfield Medical Center, Fort Worth, USA 2-Penza Institute for Postgraduate Training of Physicians, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Penza, Russia 3-Penza State University, Penza, Russia

The paper gives data on the epidemiology, classification, and nature of comorbidities in patients with osteoporosis (OP). It shows the necessity of taking comorbidities into account, which makes it possible to improve the diagnosis of OP and the efficiency of its treatment.
Keywords: 
therapy
comorbid osteoporosis
cavernous masses
fracture
bone mineral density
Osteomed Forte
OsteoVit D3
densitometry
Trabecular Bone Score

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Anohin P.K. Operezhajuschee otrazhenie dejstvitel'nosti // Vopr. filosofii. – 1962; 7: 97–111.
  2. Bojkov I.V., Strukov V.I., Semerich Ju.S. Programma opredelenija stepeni porazhenija patsienta OP. Svidetel'stvo o gosudarstvennoj registratsii programmy dlja EVM № 2013660284 ot 10.09.2013.
  3. Gerasimov I.G. Entropija biologicheskih sistem // Problemy starenija i dolgoletija. – 1998; 8 (2): 39–44.
  4. Inozemtsev O.N. Kazahskaja meditsinskaja nauchno-populjarnaja gazeta «Ekpert zdorov'ja» ot 21.10.2014.
  5. Ismailova O., Eremina N., Strukov V. i soavt. Lechenie hronicheskogo parodontita u zhenschin v postmenopauzal'nom periode s uchetom mineral'noj plotnosti kostnoj tkani // Vrach. – 2015; 10: 56–8.
  6. Kozyrev K.M., Tutaeva Z.R. Patogenez i kliniko-morfologicheskie osobennosti nejrodegenerativnyh zabolevanij u dolgozhitelej razlichnyh klimaticheskih rajonov Severnogo Kavkaza // Vestn. novyh med. tehnologij. Tula. – 2005; 12 (3–4): 120–4.
  7. Prigozhin I.R., Stingers I. Porjadok iz haosa: novyj dialog cheloveka s prirodoj / M.: Progress, 1986.
  8. Radionova I.V., Skvortsov V.V., Skvortsova E.M. i dr. Sistemnyj osteoporoz i OP nizhnej cheljusti // Meditsinskaja sestra. – 2015; 5: 32–4.
  9. Rukovodstvo po gerontologii. Pod red. V.N. Shabalina / M., 2005; s. 800.
  10. Sel'e G. Ocherki ob adaptatsionnom sindrome / M.: Medgiz, 1960; 254 s.
  11. Strukov V.I. i dr. Sposob i preparat dlja profilaktiki i lechenija atipichnogo OP s normal'noj ili povyshennoj mineralizatsiej kostnoj tkani s nalichiem polostnyh obrazovanij v trabekuljarnyh otdelah kostej. Patent na izobretenie №2497533.
  12. Dzhouns O.V., Strukov V.I. i dr. Sposob profilaktiki i lechenija OP i perelomov kostej i preparat dlja ih profilaktiki i lechenija. Patent na izobretenie №2498811. Prioritet ot 19.04.2012.
  13. Strukov V.I. i dr. Sposob diagnostiki osteoporoza metodom opredelenija dinamiki zakrytija polostnyh obrazovanij dlja otsenki effektivnosti primenenija razlichnyh osteoprotektorov. Patent na izobretenie №2511430. Prioritet s 19.04.2012.
  14. Strukov V.I., Katjushina Ju.G., Filippova O.V. Osteomed – effektivnyj reguljator mineral'noj plotnosti kostej i zakrytija polostnyh obrazovanij pri lechenii presenil'nogo i senil'nogo osteoporoza // Poliklinika. – 2013; 1 (1): 90–1.
  15. Bruyere O. et al. Strontion Ranelate on spinal osteoarthritis progression // Ann. Rheumatol. Disorder. – 2008; 67: 335–9.
  16. Kalinchenko S., Vishnevskiy E. Koval A. et al. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: A pilot study // The Aging Male. – 2008; 11 (2): 57–61.
  17. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis / Washington, DC: National Osteoporosis Foundation, 2014.
  18. Durie B., Katz M. Croweiy J. Osteonecrosis of the jaw and bifosfonates // N. Engl. J. Med. – 2005; 21: 99–102.
  19. Murad O., Arora S., Farag A. et al. Bisphosphonates and osteonecrosis of the jaw: a retrospective study // Endocr. Pract. – 2007; 13 (3): 232–8.
  20. Montebugnoli L., Felicetti L., Gissi D. et al. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. – 2007; 104 (4): 473–7.
  21. Gunther C. et al. Beneficial Effect of PTH on Spine BMD and Microarchitecture (TBS) Parameters in Postmenopausal Women with Osteoporosis. A 2-Year Study // Osteoporosis Int. – 2012; 23 (2): 85–386.
  22. Hans D. et al. Beneficial Effects of Strontium Ranelate Compared to Alendronate on TBS Menopausal Osteoporotic Women. A 2-Year Study // Osteoporosis Int. – 2012; 23 (2): 85–386.
  23. Leslie W., Kanis J. Lumbar spine TBS is a FRAX independent risk factor for fracture. The Manitoba BMD Cohort. ISCD Annual meeting 2013. Tampa, Florida.